TIG Advisors LLC’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,801,683
Closed -$130M 121
2025
Q4
$130M Buy
+1,801,683
New +$116M 6.02% 3

Other funds holding RNAM

TIG Advisors LLC's RNAM Position: Q1 2026 in Review

TIG Advisors LLC sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1,801,683 shares — an estimated $130M sold.

TIG Advisors LLC first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $130M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • TIG Advisors LLC reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • TIG Advisors LLC sold 1,801,683 Avidity Biosciences shares in Q1 2026, an estimated $130M.
  • TIG Advisors LLC first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • TIG Advisors LLC's Avidity Biosciences position peaked at $130M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on TIG Advisors LLC's 13F filing for Q1 2026, filed 15 May 2026.